SRC and melanoma: Since OXPHOS/metastasis pathway has been reported in other types of cancer besides TNBC, including pancreatic, ovarian, melanoma and prostate cancers [38–42], the CDCP1/mitochondrial Src pathway needs to be further investigated in these cancer cell contexts.